We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+0.48%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$263M
AUM Growth
+$7.9M
Cap. Flow
+$8.82M
Cap. Flow %
3.36%
Top 10 Hldgs %
45.52%
Holding
58
New
24
Increased
7
Reduced
13
Closed
12

Top Buys

Rank Stock Value
1
ARLZ
Aralez Pharmaceuticals Inc.
ARLZ
+$10.1M
2
SGI
Somnigroup International
SGI
+$8.5M
3
THC icon
Tenet Healthcare
THC
+$6.74M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$6.47M
5
ENTA icon
Enanta Pharmaceuticals
ENTA
+$6.28M

Top Sells

Rank Stock Value
1
XNPT
XENOPORT, INC.
XNPT
+$12.8M
2
AVTA
Avantax, Inc. Common Stock
AVTA
+$11.1M
3
TVTY
Tivity Health, Inc. Common Stock
TVTY
+$8.48M
4
VNDA icon
Vanda Pharmaceuticals
VNDA
+$7.75M
5
TBPH icon
Theravance Biopharma
TBPH
+$7.52M

Sector Composition

Rank Sector Weight
1 Healthcare 38.23%
2 Consumer Discretionary 24.75%
3 Consumer Staples 7.97%
4 Financials 1.97%
5 Communication Services 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$37.7M 14.36%
180,000
-100,000
-36% -$20.7M
ATRS
2
DELISTED
Antares Pharma, Inc.
ATRS
$16.2M 6.17%
15,430,000
+24,297
+0.2% +$23.5K
VNDA icon
3
Vanda Pharmaceuticals
VNDA
$327M
$8.95M 3.41%
800,000
-800,000
-50% -$7.75M
ARLZ
4
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$8.79M 3.35%
+2,664,000
New +$10.1M
TLRD
5
DELISTED
Tailored Brands, Inc.
TLRD
$8.71M 3.32%
688,000
+288,000
+72% +$4.26M
RXDX
6
DELISTED
Ignyta, Inc.
RXDX
$8.43M 3.21%
1,556,000
-132,000
-8% -$878K
SGI
7
Somnigroup International
SGI
$15.3B
$7.97M 3.03%
+576,000
New +$8.5M
BWLD
8
DELISTED
Buffalo Wild Wings, Inc.
BWLD
$7.78M 2.96%
56,000
+24,000
+75% +$3.4M
HAIN icon
9
Hain Celestial
HAIN
$50.6M
$7.56M 2.88%
152,000
-72,000
-32% -$3.33M
HAIN icon
10
CALL
Hain Celestial
HAIN
$50.6M
$7.46M 2.84%
+150,000
New +$6.94M
LVS icon
11
Las Vegas Sands
LVS
$30.1B
$7.13M 2.72%
164,000
+40,000
+32% +$1.87M
FRPT icon
12
Freshpet
FRPT
$2.78B
$7M 2.66%
750,000
-622,000
-45% -$5.37M
HZNP
13
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$6.59M 2.51%
+400,000
New +$6.47M
NOMD icon
14
Nomad Foods
NOMD
$1.61B
$6.38M 2.43%
800,000
+232,000
+41% +$2.05M
THC icon
15
Tenet Healthcare
THC
$16.8B
$6.3M 2.4%
+228,000
New +$6.74M
BDSI
16
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$6.26M 2.38%
2,652,000
-60,000
-2% -$166K
ACOR
17
DELISTED
Acorda Therapeutics
ACOR
$5.92M 2.25%
1,933
-1,050
-35% -$3.41M
SNY icon
18
Sanofi
SNY
$107B
$5.78M 2.2%
+138,000
New +$5.66M
DECK icon
19
Deckers Outdoor
DECK
$14.8B
$5.75M 2.19%
600,000
+240,000
+67% +$2.22M
KATE
20
DELISTED
Kate Spade & Company
KATE
$5.32M 2.02%
258,000
+34,000
+15% +$775K
ENTA icon
21
Enanta Pharmaceuticals
ENTA
$400M
$5.29M 2.01%
+240,000
New +$6.28M
AVTA
22
DELISTED
Avantax, Inc. Common Stock
AVTA
$5.18M 1.97%
500,000
-1,408,000
-74% -$11.1M
SGYP
23
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$5.05M 1.92%
1,330,000
-870,000
-40% -$2.95M
BHC icon
24
CALL
Bausch Health
BHC
$1.8B
$4.83M 1.84%
+240,000
New +$6.8M
TTWO icon
25
Take-Two Interactive
TTWO
$43.9B
$4.55M 1.73%
120,000
-4,000
-3% -$147K
1
2 3

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.61B AUM 19.63% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
AIM
Alphinity Investment Management Sydney, Australia $5.68B AUM 26.72% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return

Armistice Capital's Q2 2016 Portfolio in Review

As of Q2 2016, Armistice Capital held 58 positions worth $263M, up 3.1% from $255M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Armistice Capital deployed $8.82M of net new capital in Q2 2016, opening 24 new positions and adding to 7 existing holdings. Its largest new stake was Aralez Pharmaceuticals Inc.: 2,664,000 shares worth $8.79M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 38% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Avantax, Inc. Common Stock, an estimated $11.1M trimmed.

  • Armistice Capital's largest Q2 2016 buy was Aralez Pharmaceuticals Inc.: 2,664,000 shares worth $8.79M.
  • Armistice Capital added most to Tailored Brands, Inc. in Q2 2016, an estimated $4.26M increase.
  • Armistice Capital's biggest Q2 2016 reduction was Avantax, Inc. Common Stock, cutting an estimated $11.1M.
  • Armistice Capital fully exited XENOPORT, INC. in Q2 2016, selling an estimated $12.8M.
  • Armistice Capital's ten largest holdings make up 46% of its $263M portfolio in Q2 2016.
  • Armistice Capital opened 24 new positions and closed 12 in Q2 2016.
  • Armistice Capital's portfolio value rose 3.1% quarter-over-quarter to $263M.

Based on Armistice Capital's 13F filing for Q2 2016, filed 15 Aug 2016.